Signs of overdose may include muscle weakness, ataxia, dysarthria and particularly in children paradoxical excitement. In more severe cases diminished reflexes, confusion, and coma may ensue.
Adinazolam (Deracyn®) is a benzodiazepine derivative with anxiolytic, anticonvulsant, sedative, and antidepressant properties. Adinazolam was first developed to enhance the antidepressant effects of alprazolam. It has never been approved by the FDA for clinical use.
Fitur visualisasi ini dikembangkan menggunakan pendekatan Graph Theory untuk memetakan hubungan polifarmasi dan molekuler. Entitas (Obat, Target, Gen) direpresentasikan sebagai Simpul (Nodes), sedangkan hubungan biologisnya sebagai Sisi (Edges).
drugbank-id dan name pada skema XML DrugBank.targets/target yang memuat polipeptida sasaran.gene-name dan varian snp-effects.Tata letak grafik menggunakan algoritma Force-Directed Graph (Barnes-Hut). Model fisika ini menerapkan gaya tolak-menolak antar simpul (Gravitasi: -3000) agar tidak tumpang tindih, serta gaya pegas (Spring: 0.04) pada garis penghubung untuk fleksibilitas interaksi.
| Buprenorphine | Adinazolam may increase the central nervous system depressant (CNS depressant) activities of Buprenorphine. |
| Doxylamine | Doxylamine may increase the central nervous system depressant (CNS depressant) activities of Adinazolam. |
| Dronabinol | Dronabinol may increase the central nervous system depressant (CNS depressant) activities of Adinazolam. |
| Droperidol | Droperidol may increase the central nervous system depressant (CNS depressant) activities of Adinazolam. |
| Hydrocodone | Adinazolam may increase the central nervous system depressant (CNS depressant) activities of Hydrocodone. |
| Hydroxyzine | Hydroxyzine may increase the central nervous system depressant (CNS depressant) activities of Adinazolam. |
| Magnesium sulfate | The therapeutic efficacy of Adinazolam can be increased when used in combination with Magnesium sulfate. |
| Methotrimeprazine | Adinazolam may increase the central nervous system depressant (CNS depressant) activities of Methotrimeprazine. |
| Metyrosine | Adinazolam may increase the sedative activities of Metyrosine. |
| Minocycline | Minocycline may increase the central nervous system depressant (CNS depressant) activities of Adinazolam. |
| Mirtazapine | Adinazolam may increase the central nervous system depressant (CNS depressant) activities of Mirtazapine. |
| Nabilone | Nabilone may increase the central nervous system depressant (CNS depressant) activities of Adinazolam. |
| Orphenadrine | Adinazolam may increase the central nervous system depressant (CNS depressant) activities of Orphenadrine. |
| Paraldehyde | Adinazolam may increase the central nervous system depressant (CNS depressant) activities of Paraldehyde. |
| Perampanel | Perampanel may increase the central nervous system depressant (CNS depressant) activities of Adinazolam. |
| Pramipexole | Adinazolam may increase the sedative activities of Pramipexole. |
| Ropinirole | Adinazolam may increase the sedative activities of Ropinirole. |
| Rotigotine | Adinazolam may increase the sedative activities of Rotigotine. |
| Rufinamide | The risk or severity of adverse effects can be increased when Rufinamide is combined with Adinazolam. |
| Suvorexant | Adinazolam may increase the central nervous system depressant (CNS depressant) activities of Suvorexant. |
| Tapentadol | Tapentadol may increase the central nervous system depressant (CNS depressant) activities of Adinazolam. |
| Thalidomide | Adinazolam may increase the central nervous system depressant (CNS depressant) activities of Thalidomide. |
| Zolpidem | Adinazolam may increase the central nervous system depressant (CNS depressant) activities of Zolpidem. |
| Clozapine | The risk or severity of adverse effects can be increased when Adinazolam is combined with Clozapine. |
| Methadone | Adinazolam may increase the central nervous system depressant (CNS depressant) activities of Methadone. |
| Olanzapine | The risk or severity of adverse effects can be increased when Adinazolam is combined with Olanzapine. |
| Sodium oxybate | Adinazolam may increase the central nervous system depressant (CNS depressant) activities of Sodium oxybate. |
| Teduglutide | The serum concentration of Adinazolam can be increased when it is combined with Teduglutide. |
| Yohimbine | The therapeutic efficacy of Adinazolam can be increased when used in combination with Yohimbine. |
| Dicoumarol | The risk or severity of adverse effects can be increased when Adinazolam is combined with Dicoumarol. |
| Phenindione | The risk or severity of adverse effects can be increased when Adinazolam is combined with Phenindione. |
| Coumarin | The risk or severity of adverse effects can be increased when Adinazolam is combined with Coumarin. |
| Tioclomarol | The risk or severity of adverse effects can be increased when Adinazolam is combined with Tioclomarol. |
| Warfarin | The risk or severity of adverse effects can be increased when Adinazolam is combined with Warfarin. |
| Phenprocoumon | The risk or severity of adverse effects can be increased when Adinazolam is combined with Phenprocoumon. |
| Acenocoumarol | The risk or severity of adverse effects can be increased when Adinazolam is combined with Acenocoumarol. |
| 4-hydroxycoumarin | The risk or severity of adverse effects can be increased when Adinazolam is combined with 4-hydroxycoumarin. |
| (R)-warfarin | The risk or severity of adverse effects can be increased when Adinazolam is combined with (R)-warfarin. |
| Ethyl biscoumacetate | The risk or severity of adverse effects can be increased when Adinazolam is combined with Ethyl biscoumacetate. |
| Fluindione | The risk or severity of adverse effects can be increased when Adinazolam is combined with Fluindione. |
| Clorindione | The risk or severity of adverse effects can be increased when Adinazolam is combined with Clorindione. |
| Diphenadione | The risk or severity of adverse effects can be increased when Adinazolam is combined with Diphenadione. |
| (S)-Warfarin | The risk or severity of adverse effects can be increased when Adinazolam is combined with (S)-Warfarin. |
| Ethanol | Adinazolam may increase the central nervous system depressant (CNS depressant) activities of Ethanol. |
| Azelastine | Adinazolam may increase the central nervous system depressant (CNS depressant) activities of Azelastine. |
| Brimonidine | Brimonidine may increase the central nervous system depressant (CNS depressant) activities of Adinazolam. |
| Zimelidine | The risk or severity of adverse effects can be increased when Adinazolam is combined with Zimelidine. |
| Dapoxetine | The risk or severity of adverse effects can be increased when Adinazolam is combined with Dapoxetine. |
| Seproxetine | The risk or severity of adverse effects can be increased when Adinazolam is combined with Seproxetine. |
| Fluvoxamine | The risk or severity of adverse effects can be increased when Adinazolam is combined with Fluvoxamine. |
| Citalopram | The risk or severity of adverse effects can be increased when Adinazolam is combined with Citalopram. |
| Duloxetine | The risk or severity of adverse effects can be increased when Adinazolam is combined with Duloxetine. |
| Trazodone | The risk or severity of adverse effects can be increased when Adinazolam is combined with Trazodone. |
| Paroxetine | The risk or severity of adverse effects can be increased when Adinazolam is combined with Paroxetine. |
| Sertraline | The risk or severity of adverse effects can be increased when Adinazolam is combined with Sertraline. |
| Sibutramine | The risk or severity of adverse effects can be increased when Adinazolam is combined with Sibutramine. |
| Escitalopram | The risk or severity of adverse effects can be increased when Adinazolam is combined with Escitalopram. |
| Milnacipran | The risk or severity of adverse effects can be increased when Adinazolam is combined with Milnacipran. |
| Desvenlafaxine | The risk or severity of adverse effects can be increased when Adinazolam is combined with Desvenlafaxine. |
| Levomilnacipran | The risk or severity of adverse effects can be increased when Adinazolam is combined with Levomilnacipran. |
| Indalpine | The risk or severity of adverse effects can be increased when Adinazolam is combined with Indalpine. |
| Ritanserin | The risk or severity of adverse effects can be increased when Adinazolam is combined with Ritanserin. |
| Alaproclate | The risk or severity of adverse effects can be increased when Adinazolam is combined with Alaproclate. |
| Cyproheptadine | The risk or severity of CNS depression can be increased when Cyproheptadine is combined with Adinazolam. |
| Propiomazine | The risk or severity of CNS depression can be increased when Adinazolam is combined with Propiomazine. |
| Nicardipine | The metabolism of Adinazolam can be decreased when combined with Nicardipine. |
| Zopiclone | The risk or severity of adverse effects can be increased when Adinazolam is combined with Zopiclone. |
| Caffeine | The therapeutic efficacy of Adinazolam can be decreased when used in combination with Caffeine. |
| Dyphylline | The therapeutic efficacy of Adinazolam can be decreased when used in combination with Dyphylline. |
| Pentoxifylline | The therapeutic efficacy of Adinazolam can be decreased when used in combination with Pentoxifylline. |
| Mercaptopurine | The therapeutic efficacy of Adinazolam can be decreased when used in combination with Mercaptopurine. |
| Oxtriphylline | The therapeutic efficacy of Adinazolam can be decreased when used in combination with Oxtriphylline. |
| Theobromine | The therapeutic efficacy of Adinazolam can be decreased when used in combination with Theobromine. |
| Fenethylline | The therapeutic efficacy of Adinazolam can be decreased when used in combination with Fenethylline. |
| 8-azaguanine | The therapeutic efficacy of Adinazolam can be decreased when used in combination with 8-azaguanine. |
| 7,9-Dimethylguanine | The therapeutic efficacy of Adinazolam can be decreased when used in combination with 7,9-Dimethylguanine. |
| Xanthine | The therapeutic efficacy of Adinazolam can be decreased when used in combination with Xanthine. |
| 7-Deazaguanine | The therapeutic efficacy of Adinazolam can be decreased when used in combination with 7-Deazaguanine. |
| Guanine | The therapeutic efficacy of Adinazolam can be decreased when used in combination with Guanine. |
| 9-Methylguanine | The therapeutic efficacy of Adinazolam can be decreased when used in combination with 9-Methylguanine. |
| Peldesine | The therapeutic efficacy of Adinazolam can be decreased when used in combination with Peldesine. |
| Hypoxanthine | The therapeutic efficacy of Adinazolam can be decreased when used in combination with Hypoxanthine. |
| 9-Deazaguanine | The therapeutic efficacy of Adinazolam can be decreased when used in combination with 9-Deazaguanine. |
| Propentofylline | The therapeutic efficacy of Adinazolam can be decreased when used in combination with Propentofylline. |
| Valomaciclovir | The therapeutic efficacy of Adinazolam can be decreased when used in combination with Valomaciclovir. |
| 3-isobutyl-1-methyl-7H-xanthine | The therapeutic efficacy of Adinazolam can be decreased when used in combination with 3-isobutyl-1-methyl-7H-xanthine. |
| Uric acid | The therapeutic efficacy of Adinazolam can be decreased when used in combination with Uric acid. |
| Doxofylline | The therapeutic efficacy of Adinazolam can be decreased when used in combination with Doxofylline. |
| 6-O-benzylguanine | The therapeutic efficacy of Adinazolam can be decreased when used in combination with 6-O-benzylguanine. |
| Lisofylline | The therapeutic efficacy of Adinazolam can be decreased when used in combination with Lisofylline. |
| Lobucavir | The therapeutic efficacy of Adinazolam can be decreased when used in combination with Lobucavir. |
| Cafedrine | The therapeutic efficacy of Adinazolam can be decreased when used in combination with Cafedrine. |
| Theodrenaline | The therapeutic efficacy of Adinazolam can be decreased when used in combination with Theodrenaline. |
| Bamifylline | The therapeutic efficacy of Adinazolam can be decreased when used in combination with Bamifylline. |
| Proxyphylline | The therapeutic efficacy of Adinazolam can be decreased when used in combination with Proxyphylline. |
| Acefylline | The therapeutic efficacy of Adinazolam can be decreased when used in combination with Acefylline. |
| Etamiphylline | The therapeutic efficacy of Adinazolam can be decreased when used in combination with Etamiphylline. |
| Pentifylline | The therapeutic efficacy of Adinazolam can be decreased when used in combination with Pentifylline. |
| Bufylline | The therapeutic efficacy of Adinazolam can be decreased when used in combination with Bufylline. |
| Bromotheophylline | The therapeutic efficacy of Adinazolam can be decreased when used in combination with Bromotheophylline. |